Sector: Medical
Industry: Medical-Biomed & Genetics
3-Year Growth Rate: 154%
2015 Revenue: $753,751,000
2012 Revenue: $297,059,000
Stock Ticker: INCY
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.
